Marsico Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Marsico Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-101,722	Closed	-$63.4M	–	92
2020 Q2	$63.4M	Buy	+101,722	New	+$57.7M	1.99%	16
2016 Q2	–	Sell	-3,398	Closed	-$1.23M	–	95
2016 Q1	$1.23M	Sell	3,398 -223,631	-99%	-$92.2M	0.04%	82
2015 Q4	$123M	Sell	227,029 -19,288	-8%	-$10.5M	2.18%	19
2015 Q3	$115M	Buy	246,317 +191,970	+353%	+$103M	1.19%	24
2015 Q2	$27.7M	Sell	54,347 -1,669	-3%	-$815K	0.24%	54
2015 Q1	$25.3M	Buy	+56,016	New	+$23.7M	0.21%	57

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marsico Capital Management's REGN Position: Q3 2020 in Review

Marsico Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 101,722 shares — an estimated $63.4M sold.

Marsico Capital Management first reported a position in REGN in Q1 2015 and held it in 6 quarters. The position peaked at $123M in Q4 2015. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

Marsico Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Marsico Capital Management sold 101,722 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $63.4M.
Marsico Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Marsico Capital Management's Regeneron Pharmaceuticals position peaked at $123M in Q4 2015.
907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Marsico Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.